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Abstract
Francisella tularensis is a gram-negative facultative bacterium that causes the disease tularemia, even upon exposure to low
numbers of bacteria. One critical characteristic of Francisella is its ability to dampen or subvert the host immune response. In
order to help understand the mechanisms by which this occurs, we performed Affymetrix microarray analysis on transcripts
from blood monocytes infected with the virulent Type A Schu S4 strain. Results showed that expression of several host
response genes were reduced such as those associated with interferon signaling, Toll-like receptor signaling, autophagy and
phagocytosis. When compared to microarrays from monocytes infected with the less virulent F. tularensis subsp. novicida,
we found qualitative differences and also a general pattern of quantitatively reduced pro-inflammatory signaling pathway
genes in the Schu S4 strain. Notably, the PI3K / Akt1 pathway appeared specifically down-regulated following Schu S4
infection and a concomitantly lower cytokine response was observed. This study identifies several new factors potentially
important in host cell subversion by the virulent Type A F. tularensis that may serve as novel targets for drug discovery.
Citation: Butchar JP, Cremer TJ, Clay CD, Gavrilin MA, Wewers MD, et al. (2008) Microarray Analysis of Human Monocytes Infected with Francisella tularensis
Identifies New Targets of Host Response Subversion. PLoS ONE 3(8): e2924. doi:10.1371/journal.pone.0002924
Editor: Mauricio Martins Rodrigues, Federal University of Sa ˜o Paulo, Brazil
Received May 15, 2008; Accepted July 18, 2008; Published August 13, 2008
Copyright:  2008 Butchar et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was sponsored by the NIH/NIAID Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research (RCE) Program.
The authors wish to acknowledge membership within and support from the Region V ‘Great Lakes’ RCE (NIH award 1-U54-AI-057153). This work was also
supported by NIH grants R01 AI059406 and P01 CA095426 to ST.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: jon.butchar@osumc.edu
Introduction
Francisella tularensis is a gram-negative facultative bacterium that
is phagocytosed by mononuclear phagocytes [1] and polymor-
phonuclear leukocytes in the presence of serum [1,2], and also
enters epithelial cells [3]. F. tularensis, similar to pathogens like L.
Monocytogenes [4] is known as a stealth pathogen as it escapes the
phagosome and replicates inside the host cell cytosol [5],
eventually leading to host cell death [6,7]. How this bacterium is
able to evade normal phagolysosomal fusion and continue to
survive and proliferate is of great interest.
To help shed light on how F. tularensis survives successfully inside
the host cell, we previously performed Affymetrix oligonucleotide
microarray analysis to examine genome wide transcriptional
responses of human monocytes to the lesser virulent F. novicida subsp
novicida strain. Results showed that several pro-inflammatory
mediators were up-regulated following infection [8], many of which
had been previously described such as Interferon-c (IFNc)
[9,10,11,12], Interleukin-2 (IL-2) [9,10], Interleukin-12 (IL-12) [12],
Interleukin-23 (IL-23) [8] and Interleukin-1b (IL-1b) [13,14].
However, it has been shown that after an initial pro-inflammatory
period, there is a marked down-regulation in cytokine and signaling
responses that depend on phagosomal escape [15].
Here, we have performed a microarray analysis of human
peripheral blood monocytes after infection with the highly virulent
Type A F. tularensis subsp. tularensis Schu S4 strain. We found down-
regulation of genes in several general immune response pathways
such as phagocytosis, autophagy, IFNc signaling and Toll-like
Receptor (TLR) signaling. We have extended these studies to show
that, this down-regulation of TLR pathway genes results in
dampening of the monocyte response to subsequent stimulation
with TLR ligands. Further, the PI3K / Akt pathway, shown to be
critical for optimal cytokine responses [16,17], was preferentially
down-regulated in F. tularensis subsp. tularensis Schu S4 when
compared to F. tularensis subsp. novicida infection with a concomitant
down-regulation in cytokine production. This large-scale view of
the host response to Francisella shows a pattern of dampened
monocyte responses in several pro-inflammatory pathways follow-
ing infection by a Type A prototype strain which provides greater
insight into mechanisms underlying its highly virulent nature. The
sub-optimal response by elements of these pathways uncovers
them as potential therapeutic targets.
Materials and Methods
Cells and Reagents
THP-1 cells (ATCC) and human peripheral blood monocytes
were cultured in RPMI 1640 containing 10% heat-inactivated
FBS, 2 mM L-glutamine and 50 units / ml penicillin-streptomy-
cin. Antibodies against Akt1, MyD88 and MKP1 were from Santa
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CD14 and isotype control were from BD Pharmingen (San Diego,
CA). Anti-IFNcRI was from R & D Systems (Minneapolis, MN)
and the FITC-conjugated secondary was from Caltag / Invitrogen
(Carlsbad, CA). Purified E. coli (strain 0127:B8) LPS was from
Difco (Detroit, MI) and Pam3Cys-Ser-(Lys)4 (Pam3CSK) was from
Calbiochem / EMD (San Diego, CA). Gentamicin Reagent
Solution was from Invitrogen.
Peripheral blood monocyte isolation
Human peripheral blood monocytes were isolated using either
CD14 positive or negative selection by centrifugation through a
Ficoll gradient followed by MACS (Miltenyi Biotec, Auburn, CA) in
accordance with manufacturer instructions. Flow cytometry using
CD14 antibody showed a minimum of 96% purity for each sample.
Infections
Monocytes were infected at a multiplicity of infection (MOI) of
100, with 5 million monocytes and 500 million F. tularensis novicida
or F. tularensis tularensis Schu S4, then incubated in 1 ml RPMI
with 10% FBS for 24 hours at 37u C. Bacteria were grown
overnight (approximately 18 hours) on chocolate II agar (Becton
Dickinson) at 37uC prior to use. Infections with Schu S4 were
performed in a BSL3 facility at The Ohio State University as
previously described [8].
Microarray analysis
RNA was extracted using Trizol (Invitrogen) and subsequent
labeling and hybridization to Affymetrix hgu133plus2 chips was
performed at The Ohio State University Comprehensive Cancer
Center microarray facility. Resulting data files (.CEL) were pooled
with earlier .CEL files [8] and all .CEL files were then
preprocessed and analyzed using R and BioConductor [18,19].
Expression values were calculated using the ‘‘gcrma’’ package and
both the statistical analyses for differential expression and creation
of the Venn diagram were done using the ‘‘limma’’ package [20].
Expression values and analysis results were stored in a PostgreSQL
database (http://www.postgresql.org). The data discussed in this
publication have been deposited in NCBI’s Gene Expression
Omnibus [21] and are accessible through GEO Series accession
number GSE12108 (http://www.ncbi.nlm.nih.gov/geo/query/
acc.cgi?acc=GSE12108).
Cell stimulation, lysis, Western blotting and ELISAs
Uninfected and infected cells were lysed in TN1 buffer (50 mM
Tris (pH 8.0), 10 mM EDTA, 10 mM Na4P2O7, 10 mM NaF,
1% Triton X-100, 125 mM NaCl, 10 mM Na3VO4, 10 g/ml
each aprotinin and leupeptin). Postnuclear lysates were boiled in
Laemmli sample buffer and separated by SDS-PAGE, transferred
to nitrocellulose filters, probed with the antibody of interest, then
developed by ECL (Amersham Biosciences). For F. tularensis Schu
S4 infections, cell pellets were boiled in Laemmli sample buffer as
previously described [8]. Supernatants from Schu S4-infected cells
were centrifuged (100 6 g and then 10,000 6 g), then passed
through 0.22 mm filters and samples plated to ensure that there
were no viable bacteria. ELISAs were done using sandwich ELISA
kits from R & D Systems (IL-8) and eBioscience (IL-6, IL-1b).
Flow cytometry
Cells were blocked with human IgG (Jackson ImmunoResearch,
West Grove, PA, USA) in PBS for 10 minutes, then incubated with
either PE-Cy7-conjugated anti-human CD14 antibody or isotype
control (BD Pharmingen) for 60 minutes. In parallel, cells treated
with only the FITC-conjugated goat anti-mouse antibody were
prepared. Cells were then gently centrifuged, washed in PBS, and
then resuspended in PBS containing 1% paraformaldehyde. Samples
were then run on a BD FACSCalibur machine (Becton Dickinson).
Real-time PCR
Quantitative reverse-transcription PCR was performed as
described previously [13]. Briefly, RNA was isolated from human
PBM using Trizol (Invitrogen, Carlsbad, CA), subjected to reverse
transcription and then amplified using SYBR Green PCR master
mix (Eurogentec North America, San Diego, Ca). Relative Copy
Number (‘‘RCN’’) was calculated as described previously [13].
Results and Discussion
Global transcriptional responses to F. novicida and Schu
S4
Human peripheral blood monocytes were isolated from four
buffy coats and infected with the F. tularensis tularensis Schu S4 (‘‘S4’’)
strain at 100 MOI for 24 hours. The 24 hour time point was chosen
to match our previous microarrays performed with F. novicida-
infected monocytes. These samples were then subjected to
Affymetrix microarray analysis and combined with .CEL files
generated earlier from F. tularensis novicida (‘‘FN’’) infection [8] for
preprocessing and analysis. In total, 13512 transcripts were counted
as significantly different with a fold difference of 2 or more.
One of the major goals was to compare transcriptional
responses to the virulent Schu S4 versus the less virulent F.
novicida. To acquire a general overview of these responses, these
13512 transcripts were plotted in the form of a heatmap [22]
(Figure 1A). This shows great similarity in the responses to Schu
S4 and F. novicida, agreeing with earlier findings that F. novicida
shares a similar intracellular lifecycle with that of virulent
Francisella (see [23] for review). Post-infection measurement of cell
death was not feasible, but separate tests indicate that compared to
untreated, up to 50% and 20% of the cells may have been dead
following Schu S4 and F. novicida infection, respectively. Another
test with a different donor showed no differences, however. All
array chips were normalized together, mitigating the effect of
possible differences in cell viability.
To quantify the overlap in response, a Venn diagram was created
from the 13512 regulated transcripts (Figure 1B). Of these, 29% were
unique to the F. novicida versus uninfected (‘‘UT’’), 46% were shared
with both strains versus UT, and 25% were unique to S4 versus UT.
The relatively large number of response genes unique to F. novicida or
Schu S4 raised the possibility that some of these differences may help
at least in part explain the high virulence of Schu S4. Hence, we
examined several key immune response pathway genes in greater
detail with the goal of gaining greater insight into the host cell
subversion seen with Francisella. Significantly different genes were
gathered and plotted as a heatmap (Figure S1). As demonstrated by
this Figure, several genes responded differently to the two strains of
Francisella. Below we study these in greater detail.
Down-regulation of interferon pathway genes
In our initial analysis of infected monocytes [8] we found an up-
regulation of IFNc, a cytokine shown to confer host protection in
murine models [24,25,26] and found after infections in humans and
mice [27,28,29], although the strain of mice may be important [30]
as well as route of infection [31]. IFNc has been shown to
antagonize phagosomal escape [32,33], leading to improved host
cell protection. It has also been reported that Type I interferon is
induced following a cytosolic sensing event and plays a role in the
activation of the inflammasome during F. novicida infection in mice
F. novicida versus Schu S4
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translational processing and release of IL-1b [13,14]. Hence, we
examined theexpression of interferon-relatedgenes (Figure2A). We
found that the IFNa receptor was down-regulated following both F.
novicida and Schu S4 infection, with a concomitant induction of
ligand expression with F. novicida but not with Schu S4. IFNb was
up-regulated after Schu S4 but not F. novicida infection. As
previously reported [8], IFNc was up-regulated, but Schu S4
elicited more than twice the response as F. novicida. However, the
IFNc receptor was down in both cases, suggesting that IFNc may
elicit a suboptimal response after both types of infections.
Jak proteins act downstream of IFN signaling, and we found
that Schu S4 caused a down-regulation in Jak2 with no change in
Jak1 nor Jak3. There was strong up-regulation of both Jak1 and
Jak3 and down-regulation of Jak2 after F. novicida infection,
however. The Suppressor of Cytokine Signaling 1 and 3 (SOCS1
and SOCS3) genes, negative regulators of IFNc-induced Jak/
STAT1 signaling [35] were up-regulated by both bacterial strains,
although a twofold greater SOCS3 than SOCS1 induction was
seen with F. novicida (Figure 2A).
Real-time PCR analysis was performed to verify IFNc, SOCS1
and SOCS3 responses (Figure 2B), and results confirmed up-
regulation of these genes, although significant up-regulation of
SOCS1 following F. novicida infection could not be verified. The
IFNc receptor was tested using flow cytometry after F. novicida
infection, and results showed clear down-regulation of this
receptor (Figure 2C). Collectively, these data indicate that there
is an overall suppression of the interferon signaling pathway, both
Type I and Type II, and suggest that the infected monocytes, even
if exposed to exogenous IFNa or IFNc, would exhibit a
suboptimal response. Indeed, in a recent study we have
demonstrated that F. novicida infection dampens the ability of
murine macrophages to respond optimally to IFNc, resulting in
reduced nitric oxide production and greater intracellular bacterial
growth [54].
Toll-like receptor signaling is compromised
Toll-like receptor signaling is responsible for sensing pathogens
and prompting cellular immune responses. Upon contact with the
host cell, Francisella elicits signaling through Toll-like Receptor 2
Figure 1. Transcriptional responses to F. novicida and F. tularensis Schu S4. A. Genes significantly different with an absolute fold change of 2
or greater after F. novicida or Schu S4 infection were pooled and used to create a heatmap. B. A Venn diagram of all significantly different genes that
were up- or down-regulated twofold or more, with 6214 genes common to both strains, 3909 unique to FN, 3389 unique to S4 and 41163 counted as
not different. FN: F. novicida (n=4). S4: Schu S4 (n=4). UT: untreated (n=6).
doi:10.1371/journal.pone.0002924.g001
F. novicida versus Schu S4
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very weak TLR4 signaling [38,39] that depends on the co-receptor
CD14 for greatest activity [40]. We found that TLR1,4,5,6,7 and
8 were all down-regulated following infection with either F. novicida
or Schu S4 (Figure 3A). TLR2, however, was up-regulated with F.
novicida infection as previously reported for F. tularensis Live
Vaccine Strain [41] yet markedly down-regulated with Schu S4
(Figure 3A). Regulation of TLR2, TLR4, CD14, MyD88,
PYCARD and IRAK-M were verified by real-time PCR analysis
(Figure 3B). As CD14 interacts with both TLR4 [42] and TLR2
[43,44], the data suggest that signaling through either TLR
pathway would be suboptimal. Flow cytometry using F. novicida-
infected monocytes showed a strong down-regulation of CD14
(Figure 4A). Similarly, the downstream mediator MyD88 [45,46]
was decreased at the protein level (Figure 4B). The inflammasome
protein PYCARD (ASC) [47] was reduced following infection,
while the negative regulator IRAK-3 (IRAK-M) was increased
(Figure 3B). Further, a negative regulator of TLR pathway
activity, MKP1 (DUSP1) [48], was increased (Figure 4C),
although the 3.69-fold increase with Schu S4 did not reach
statistical significance (p=0.057, Figure 3A). This overall pattern
of regulation suggests that after infection, TLR signaling would be
compromised.
Consistent with this, we found that the monocytic cell line THP-
1 showed significant hyporesponsiveness to TLR4 (Figure 4D, left
panel) and TLR2 (Figure 4D, right panel) stimuli following F.
novicida infection, as measured by TNFa ELISA. The same
experiment using Schu S4 led to similar results, with THP-1 cells
being hyporesponsive to TLR4 (Figure 4E, left panel) and TLR2
(Figure 4E, right panel). These results agree closely with studies in
the murine system that showed hyporesponsiveness to TLR
stimulation after Francisella infection [49,50].
Although TLR2 expression was increased after infection with F.
novicida, the down-regulation of CD14 and MyD88 along with up-
regulation of MKP1 and IRAK-3 offer a molecular mechanism for
why TLR responses are dampened following Francisella infection.
Up-regulation of the negative regulator MKP1 was not found to
be statistically significant after Schu S4 infection, but the
expression of TLR2 itself was significantly down-regulated. Hence,
although hyporesponsiveness was demonstrated following infec-
tion with either strain, the TLR2 pathway, responsible for
inflammatory responses to Francisella [36,37], may be specifically
compromised by the virulent strain.
Schu S4 down-regulates the PI3K / Akt pathway and
inflammatory cytokine production
We recently demonstrated that activation of the PI3K/Akt
pathway is critical for the activation of NFkB and the subsequent
pro-inflammatory gene transcription during F. novicida infection
[16]. Thus, we examined the regulation of this pathway by first
examining the expression of genes in the phosphoinositol and
Figure 2. Francisella-induced changes in IFNc pathway-related genes. A. List of IFN, Jak and SOCS genes regulated by Francisella infection
(both F. novicida and Schu S4) from the microarray analysis. Fold changes of genes not statistically different are denoted ‘‘NS’’. B. Real-time PCR of
IFNc, SOCS1 and SOCS3 from human PBM infected with either F. novicida (‘‘FN’’) or Schu S4 (‘‘S4’’) at 100 MOI for 24 hours (n=8). ‘‘RCN’’ is Relative
Copy Number for the Y axis. Asterisks denote statistical significance (p#0.05) versus uninfected. C. Flow cytometry for the IFNc receptor following F.
novicida infection of human monocytes. The data are representative of three independent experiments.
doi:10.1371/journal.pone.0002924.g002
F. novicida versus Schu S4
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expression values for genes significantly different in the untreated
versus F. novicida, untreated versus Schu S4 or F. novicida versus
Schu S4 comparisons (Figure S1). Compared to untreated,
infection with both strains led to substantial down-regulation of
these pathway members. In addition, more genes were down-
regulated after Schu S4 infection compared to F. novicida such as
PIK3R1 (p85 subunit of PI3K) and Akt1 (Figure S1 and
Figure 5A). These results suggest that both strains dampen
PI3K/Akt signaling, but Schu S4 elicits a stronger dampening. We
then tested the expression of Akt1 at the protein level since it has
been shown to be critical for cytokine responses [16,17]. As
expected, Western blotting of lysates from human monocytes
infected with either F. novicida or Schu S4 indicated a strong
decrease at the protein level in Schu S4-infected cells but not in F.
novicida-infected cells (Figure 5B). This, especially in combination
with the reduced TLR2, predicts that cytokine responses would be
lower with Schu S4 than with F. novicida infection.
Consistent with reduced TLR2 and PI3K/Akt, real-time PCR
analysis showed that although IL-8, IL-6 and IL-1b were induced
by both bacterial strains, Schu S4 elicited significantly less
transcript than F. novicida (Figure 5C). Protein levels were also
significantly lower with Schu S4 as measured by ELISAs
(Figure 5D). Hence, it appears that the Schu S4 strain of Francisella
elicits a significantly lower pro-inflammatory response than the less
virulent subspecies. The suppressive effect of Schu S4 on members
of the PI3K and Toll-like receptor pathways, both necessary for
Francisella-induced NFkB-dependent gene transcription, represents
a fundamental weakness in the host inflammatory response to
Francisella infection.
In examining genes involved in other host defense mechanisms,
we found that both strains of Francisella led to decreases in MHC
Class II genes (Figure S2, panel A). Similarly, genes involved with
autophagy, a process which can also contribute to antigen
presentation [51], were down-regulated (Figure S2, panel B).
Francisella has been shown to re-enter the endocytic pathway via
autophagy following phagosomal escape and cytoplasmic replica-
tion, and this can be reversibly blocked by chloramphenicol
treatment [52]. Perhaps the down-regulation in autophagy-related
genes reflects control by Francisella during its replication phase in
the cytoplasm as suggested by Cheeroun et al.
In addition, phagocytosis-related genes were decreased includ-
ing Fcc receptors, the mannose receptor, complement components
and receptors, scavenger receptors [53] and the phagocytic
Figure 3. Toll-like receptor pathway genes affected by Francisella.A .List of TLR pathway genes from the microarray analysis. Fold changes of
genes not statistically different are denoted ‘‘NS’’. B. Real-time PCR analyses of CD14, TLR2, TLR4, MyD88, PYCARD and IRAK-M from human PBM
infected with either F. novicida (‘‘FN’’) or Schu S4 (‘‘S4’’) at an MOI of 100 for 24 hours (n=8). ‘‘RCN’’ is Relative Copy Number for the Y axis. Asterisks
denote statistical significance (p#0.05) versus uninfected.
doi:10.1371/journal.pone.0002924.g003
F. novicida versus Schu S4
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S3). There were some differences, however, between F. novicida
and Schu S4 with regard to regulation of various phagocytic
pathway members. Fyn and Scavenger Receptor F1 were up-
regulated in only F. novicida-infected monocytes, and FccRIIa was
significantly decreased in only Schu S4-infected monocytes.
Collectively, these data suggest that Francisella infection decreases
the ability of monocytes to ingest subsequent particles or
pathogens.
Taken together, these results point to several subversive
mechanisms that may help explain the virulence of F. tularensis
Schu S4 and reinforce its reputation as a stealth pathogen. The
quantitative differences in cytokine response may be attributable to
the qualitative differences seen, especially with p85 and Akt1
expression. The nature of these qualitative differences suggests that
Schu S4 actively suppresses, rather than simply bypasses, the host
innate immune response.
Although several categories of immune response genes were
affected, augmenting the PI3K/Akt1 pathway could be examined
as a possible means to combat Francisella infection, especially in the
event that antibiotic-resistant strains become commonplace.
Indeed, in mice it has been shown that overactive Akt1 confers
a survival advantage [17]. Francisella tularensis Schu S4 down-
regulates the PI3K and Akt1 genes, so identifying the mecha-
nism(s) by which this happens and / or examining events
downstream of Akt1 that are responsible for the survival advantage
may lead to specific ways to combat tularemia, perhaps as an
augmentation to standard antibiotic treatment.
It must also be considered that, as shown by Andersson et al.
[55] the transcriptional responses to Francisella are often dynamic.
Future transcriptional analyses on human monocytes could be
done using different timepoints. Finally, an examination of isolated
cells versus cocultured cells may yield more insights, as
intercellular communication can affect cellular responses.
Supporting Information
Figure S1 Genes with ontology entries of ‘‘phosphoinositol,’’
‘‘phosphoinositide,’’ ‘‘protein kinase B,’’ ‘‘antigen,’’ ‘‘autophagy,’’
‘‘interferon,’’ ‘‘Toll,’’ ‘‘phagocytosis,’’ ‘‘JAK-STAT’’ or ‘‘cytokine’’
that were significantly different in untreated versus F. novicida or
untreated versus Schu S4 comparisons with a fold difference of at
least 3 were chosen for the plot. Highlighted in yellow are genes
verified by either real-time PCR or Western blotting. Blue
indicates low expression and red high expression. Row-by-row
scaling was done for the color mapping.
Found at: doi:10.1371/journal.pone.0002924.s001 (2.24 MB TIF)
Figure 4. Hyporesponsiveness of TLR signaling after Francisella infection. A. Flow cytometry of CD14 in infected versus uninfected
monocytes, gating on live cells by scatter. B and C. Western blot of MyD88 (B) and MKP1 / DUSP1 (C) after F. novicida infection of THP-1 cells. Actin
reprobes (bottom panels) show equal loading. D and E. THP-1 cells were first infected with F. novicida (D) or Schu S4 (E) for 14 hours or left
uninfected. Uninfected and infected cells were then treated with gentamicin at 50 mg/ml to kill extracellular bacteria and restimulated with LPS
(500 ng/ml, D and E left panels) or Pam3CSK (100 ng/ml, D and E right panels) for 8 hours. Cell supernatants were analyzed for TNFa by ELISA. Values
from three independent infections were analyzed by student’s t-test. Asterisks denote statistical significance (p#0.05).
doi:10.1371/journal.pone.0002924.g004
F. novicida versus Schu S4
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the microarray analysis. An ‘‘NS’’ in the Fold Change column
denotes a non-significant change. A. Table of genes involved in
antigen presentation. B. Table of autophagy-related genes.
Found at: doi:10.1371/journal.pone.0002924.s002 (1.03 MB TIF)
Figure S3 Genes involved in phagocytosis, from the microarray
analysis. An ‘‘NS’’ in the Fold Change column denotes a non-
significant change.
Found at: doi:10.1371/journal.pone.0002924.s003 (1.26 MB TIF)
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